Vermilion ETF Pathfinder: Actionable ETF research & Ideas
Local Bottom With Potential to be a Major BottomSince late-February (2/25/25 Compass) we were expecting an 8-10% pullback to provide a buying opportunity. All that changed as of our 3/31/25 ETF Pathfinder, when we downgraded our outlook to bearish/cautious, citing several concerning developments. It all led us to believe a break below 5500 and the potential for a prolonged downturn was increasingly likely. A historic selloff ensued. We did get positive trade news and some accommodative comments from the Fed last week after the S&P 500 and Nasdaq 100 (QQQ) tested major supports, so there is at least a possibility that the lows are in. However, until market dynamics improve, we remain cautious, and we continue to favor defensives as long as the S&P 500 is below its 200-day MA.
Auxly Cannabis Group is engaged in the merchant banking business and operates in a single operating segment within Canada. It enables the private companies in which it invests (the "Investee Companies") the ability to issue debt instruments that are eligible for registered plans as defined in the Income Tax Act (Canada). Co. earns fees from the Investee Companies which are independently managed and operated by their respective management companies. Although Co. owns all or a majority of the voting rights in these Investee Companies, it does not have the power to govern the decisions or policies of the Investee Companies.
Vermilion Research delivers timely, actionable, and unique research inputs to professional investors. Our research strategists highlight securities which we believe are at major inflection points, based on our various proprietary technical indicators, and offer asymmetric risk/return profiles. We believe our research methodology, which is not limited by industry sector or market capitalization, enables us to deliver superior investment recommendations.
Our process begins by organizing all actively traded stocks into coherent sectors, then into logical industry groups. We then apply our proprietary relative strength tools to identify developing price trends. Once attractive trends are identified within a selected sectors or groups, we screen for individual stocks which we believe offer the best risk/reward profile. Vermilion offers U.S. and global equity market research products. Vermilion’s research team, which has received numerous awards and accolades, has a combined 70 year of experience in the analysis of investment securities.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.